WeFund Ventures

WeFund Ventures is a venture capital firm established in 2017 and headquartered in Tallinn, Estonia, with an additional office in Berlin, Germany. The firm specializes in early-stage investments across various sectors, including agritech, fintech, blockchain, security, biotech, enterprise solutions, big data, augmented reality/virtual reality, and aerospace. WeFund Ventures operates an acceleration fund that provides financing to very early-stage projects, utilizing an efficient syndicate funding structure that enhances its ability to mobilize substantial resources quickly and flexibly. The firm aims to support promising projects and drive innovation in its targeted industries.

Alex Glotov

Partner

Dmytro Ruzhytskyi

Partner

Alex Skubenko

CEO

2 past transactions

Payris

Seed Round in 2019
Payris is an ecosystem where customers publish their wishes and businesses complete them. Using Payris, consumer can publish a wish, get connected to a supplier who can complete the wish, and get rewarded for making their wishes come true through the app. Vendors may use Payris to buy hot leads and data for research. The platform tackles and solves the problem of social networks collecting and exploiting user data for free – Payris rewards users for sharing their wishes and completing surveys.

A.D.A.M.

Seed Round in 2018
A.D.A.M. is a 3D bioprinting company developing a Point-of-Care Medical Device Production System for in-hospital manufacturing of personalized bone implants. The system combines proprietary 3D printing technology, materials, and software to produce bioresorbable, patient-specific implants that are printed, sterilized, and prepared for implantation. The company offers a turnkey solution installed and maintained at hospitals on a subscription basis, aiming to cut end-to-end costs, shorten surgery times, and create new revenue streams for hospitals. By enabling in-house production, A.D.A.M. addresses scalability and cost barriers associated with purchasing printers, materials, and software separately, and plans to expand the portfolio to additional implants and tissues, ultimately pursuing an on-demand tissue manufacturing platform for personalized medical devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.